RE:RE:RE:Treatment of our competitor TST rejected by FDA!What happened to Telesta!!!
Wow! You have to feel sorry for those investors that lost alot of money today. This is truly an eye-opener when it comes to regulatory bodies being instrumental in the value of a biotech company!
This goes to show you how risky the biotech industry is, as this company called "Telesta" was recently worth 300 million and today it is a 10 cent stock valued at 25 million. This company seems to be a cooked chicken.
I hope TLT can see this and learn from this as we need to work hand in hand with the FDA for these approval processes to work in our favour because the stock price or company will be finished if we do not and the game is over. Sad day for those TST investors.
Yes, it is good for TLT but overall it is a scary feeling. Maybe we will see some TST shareholders begin to flood our way and buy some Theralase....increased demand for our company.